Oncologist Retires After 39 Years of Service
FOR IMMEDIATE RELEASE
OHC Marketing Department
513-751-2145 ext. 10204
OHC, the region’s premier source of treatment for nearly every form of adult cancer and complex blood disorder, has announced that Ravi C. Khanna, MD, is retiring after 39 years of treating patients with cancer. Dr. Khanna’s retirement is effective December 31, 2017.
“It has been a privilege and pleasure to have taken care of my patients over the years,” said Dr. Khanna. “It has been a very satisfying professional journey for me. Throughout it, I tried to do my very best for all my patients, and in return, learned many valuable life lessons from each one of them.”
Dr. Khanna’s colleagues will assume care for his patients. “My patients will be well cared for by all of my associates, all of whom are exceptional oncologists: Daljeet Singh, MD, Filix Kencana, MD, Zaw M. Bo, MD, Joseph R. H. See, MD, and Jyothi Challa, MD.”
Dr. Khanna’s colleagues will have access to his records for an easy transition process. If patients would like to speak with someone about the transition, please call the OHC Springfield office at 937-323-5001. The doctors are available to accept new patients and provide second opinions.
At OHC, the search for new treatments is relentless, the drive to provide superior care runs deep and the fight against cancer is personal. As one of the nation’s largest independent oncology practices, OHC has renowned experts who aggressively attack cancer with every possible strategy; an in-house, nationally-recognized clinical trials program engaged in a passionate search for innovative treatment options; and counselors and navigators to help patients understand their disease, manage finances and gain power over cancer’s impact on their life.